Since 2014, Medicollect has been working with the worlds largest pharmaceutical companies, helping them recruit patients for their clinical trials.
As projects scale up, the time has come to focus on vendor qualifications. Until recently, both Novartis and MSD have completed these extensive qualification procedures and approved the Medicollect set-up.
SANOFI is the latest, scrutinizing all SOP’s submitted by Medicollect for vendor qualification, making it the third finalized procedure from a global pharmaceutical company.
As Rene Ludwigs, CEO of Medicollect, phrases it, “We are, of course, proud that global pharmaceutical companies are eager to enter into vendor partnerships with Medicollect. We focus exclusively on solving the recruitment challenges faced by companies involved with clinical trials and our services put forth the best solution the market has to offer right now”.
Want to know more?